Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Conditions:   Alopecia Universalis (AU);   Alopecia Totalis (AT) Interventions:   Drug: Vehicle;   Drug: ATI-50002 Sponsor:   Aclaris Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials